当前位置: 首页 > 期刊 > 《中国药房》 > 201810
编号:13584215
联芳基氨基噻嗪类BACE1抑制剂的3D—QSAR分析与分子对接研究(4)
http://www.100md.com 2018年5月15日 《中国药房》 201810
     參考文献

    [ 1 ] QUERFURTH HW,LAFERLA FM. Alzheimer’s disease:mechanism of disease[J]. N Engl J Med,2010,362(4):329-344.

    [ 2 ] PRINCE M,GUERCHET M,PRINA M. The Global impact of dementia:2013-2050[R]. Health Services & Population Research,2013.

    [ 3 ] LV ZY,TAN CC,YU JT,et al.Spreading of pathology in Alzheimer’s disease[J]. Neurotox Res,2017,32(4):707- 722.

    [ 4 ] MOORTHI V,PREETHI B. A review on Alzhimer’s disease:pathology,molecular conditions,managemnt and causes[J]. Asian J Pharm Clin Res,2017,10(5):27.
, 百拇医药
    [ 5 ] VASSAR R,KOVACS DM,YAN R,et al. The β-secretase enzyme BACE in health and Alzheimer’s disease:regulation,cell biology,function,and therapeutic potential[J]. J Neurosci,2009,29(41):12787-12794.

    [ 6 ] HUNT KW, COOK AW, WATTS RJ, et al. Spirocyclic β-site amyloid precursor protein cleaving enzyme 1(BACE1)inhibitors:from hit to lowering of cerebrospinal fluid (CSF)amyloid β in a higher species[J]. J Med Chem,2013,56(8):3379-3403.
, 百拇医药
    [ 7 ] CHEN JJ,LIU Q,YUAN C,et al. Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease[J]. Bioorg Med Chem Lett,2015,25(4):767-774.

    [ 8 ] MANDAL M,ZHU Z,CUMMING JN,et al. Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1(BACE1)inhibitors:conformational constraint to favor a bioactive conformation[J]. J Med Chem,2012,55(21):9331-9345.
, http://www.100md.com
    [ 9 ] MAY PC,DEAN RA,LOWE SL,et al. Robust central reduction of amyloid-β in humans with an orally available,non-peptidic β-secretase inhibitor[J]. J Neurosci,2011,31(46):16507-16516.

    [10] WU YJ,JASON G,SHI JL,et al. Discovery of S3-truncated,C-6 heteroaryl substituted aminothiazine β-site APP cleaving enzyme-1(BACE1)inhibitors[J]. J Med Chem,2016,59(18):8593-8600.

    [11] LI HN,LI FR,CHENG MS,et al. Advances on non-peptide BACE1 inhibitors[J]. Chin J Med Chem,2016,26(6):498-508.
, 百拇医药
    [12] PUTZ MV,DUDA? NA. Variational principles for mechanistic quantitative structure-activity relationship (QSAR)studies:application on uracil derivatives’ anti-HIV action[J]. Struct Chem,2013,24(6):1873-1893.

    [13] SAMMI T,SILAKARI O,RAVIKUMAR M. Three-dimensional quantitative structure-activity relationship modeling of gamma-secretase inhibitors using molecular field analysis[J]. Chem Biol Drug Des,2008,71(2):155-166.

    [14] ENTEZARI HY,SERESHTI H,SABOURY AA,et al.3D QSAR studies,pharmacophore modeling,and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors,using human carbonic anhydrase Ⅱ as a model protein[J]. J Enzym Inhib Med Chem,2017,32(1):688-700., 百拇医药(刘景陶 倪敬轩 王晓 毕毅)
上一页1 2 3 4 5下一页